0001415889-24-005107.txt : 20240223
0001415889-24-005107.hdr.sgml : 20240223
20240223174054
ACCESSION NUMBER: 0001415889-24-005107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrone Louis H.
CENTRAL INDEX KEY: 0001867666
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 24672854
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232024_100240.xml
X0508
4
2024-02-21
0000001800
ABBOTT LABORATORIES
ABT
0001867666
Morrone Louis H.
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
0
Common shares without par value
2024-02-21
4
A
0
12309
0
A
67224
D
Common shares without par value
2556
I
Profit Sharing Trust
Option (right to buy)
116.98
2024-02-21
4
A
0
46257
0
A
2025-02-21
2034-02-20
Common Shares
46257
46257
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,419 on February 21, 2025, 15,419 on February 21, 2026, and 15,419 on February 21, 2027.
/s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
2024-02-23